Convergent Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 03, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $90,000,000
Company Info
- Company Description
- Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
- Market
- Cancer therapeutics
- Location
- Cambridge, MA, USA
- Coinvestors
- Invus, OrbiMed Advisors, RA Capital Management